| Category |
Psychology, Clinical |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
New cheaper human papilloma virus mass screening strategy reduces cervical cancer incidence in Changsha city: A clinical trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yue-E Zu, Si-Feng Wang, Xing-Xing Peng, Yong-Chun Wen, Xue-Xiang Shen, Xiao-Lan Wang, Wen-Bo Liao, Ding Jia, Ji-Yang Liu and Xiang-Wen Peng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiang-Wen Peng, PhD, Professor, Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care, Hunan Normal University, No. 416 East Chengnan Road, Yuhua District, Changsha 410001, Hunan Province, China. pxw1237@163.com |
| Key Words |
Cervical cancer screening; Human papillomavirus; ThinPrep cytology test; Cost-effective; New cheaper screening strategy |
| Core Tip |
With limited funds, we designed a new strategy for human papillomavirus screening for all women in Changsha every 3 years, to increase screening coverage and reduce the incidence of cervical cancer. From 2019 to 2022, 523437 women aged 35-64 years were screened and there were 73313 human papillomavirus-positive women, with a 14% positive rate. The detection rate of precancerous lesions of cervical cancer was 0.6% and the detection rate of cervical cancer was 0.037%. The average screening cost per woman is 120 RMB, with an early detection cost coefficient of 0.15. Our screening strategy was effective and cost-effective. |
| Publish Date |
2024-10-22 08:28 |
| Citation |
<p>Zu YE, Wang SF, Peng XX, Wen YC, Shen XX, Wang XL, Liao WB, Jia D, Liu JY, Peng XW. New cheaper human papilloma virus mass screening strategy reduces cervical cancer incidence in Changsha city: A clinical trial. <i>World J Clin Oncol</i> 2024; 15(12): 1491-1500</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i12/1491.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i12.1491 |
